Company intelligence / Profile preview

MII Fund & Labs

Ramat Gan, Israel

Ownership: Private
Employees: ~10
Development stage: Other

Overview

MII Fund & Labs operates as a venture builder and incubator, primarily advancing medical device startups from concept to clinical validation. Their portfolio includes companies like TandemHear, which has developed advanced hearing aid solutions, and NervU, focusing on nerve monitoring. Most programs are in the development to early clinical trial stages, with some solutions reaching commercialization.

Therapeutic areas: Neurology
Modalities: DeviceDigital HealthNeuromodulationDiagnostic
Industry: Investors

Partnerships

Shizim Life Science GroupThe Trendlines Group

Beyond the preview

Go deeper on MII Fund & Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MII Fund & Labs.

Explore the full profile